Bambus[4,6]urils as Dual Scaffolds for Multivalent Iminosugar Presentation and Ion Transport: Access to Unprecedented Glycosidase-Directed Anion Caging Agents

Molecules. 2022 Jul 26;27(15):4772. doi: 10.3390/molecules27154772.

Abstract

Bambusurils, BU[4] and BU[6], were used for the first time as multivalent scaffolds to link glycosidases inhibitors derived from 1-deoxynojirimycin (DNJ). Two linear DNJ ligands having six or nine carbon alkyl azido linkers or a trivalent DNJ dendron were grafted onto octapropargylated BU[4] and dodecapropargylated BU[6] using copper-catalyzed cycloaddition (CuAAC) to yield corresponding neoglycobambus[4] and neoglycobambus[6]urils bearing 8 to 24 iminosugars. The inhibition potencies of neoglycoBU[4], neoglycoBU[6] and neoglycoBU[6] caging anions were evaluated against Jack Bean α-mannosidase and compared to monovalent DNJ derivatives. Strong affinity enhancements per inhibitory head were obtained for the clusters holding trivalent dendrons with inhibitory constants in the nanomolar range (Ki = 24 nM for BU[4] with 24 DNJ units). Interestingly, the anion (bromide or iodide) encapsulated inside the cavity of BU[6] does not modify the inhibition potency of neoglycoBU[6], opening the way to water-soluble glycosidase-directed anion caging agents that may find applications in important fields such as bio(in)organic chemistry or oncology.

Keywords: CuAAC; DNJ; bambusuril; enzyme inhibition; iminosugars; multivalency; α-mannosidase.

MeSH terms

  • 1-Deoxynojirimycin / pharmacology
  • Anions
  • Enzyme Inhibitors / pharmacology
  • Glycoside Hydrolases / metabolism
  • Imino Sugars* / pharmacology
  • Ion Transport

Substances

  • Anions
  • Enzyme Inhibitors
  • Imino Sugars
  • 1-Deoxynojirimycin
  • Glycoside Hydrolases